Moles are NOT the only sign of deadly skin cancer: Most melanoma patients 'have fewer than 20 - and none that look dangerous'

www.ok-biotech.com

• Total number of moles and abnormal moles have long been linked to an increased risk of melanoma - the deadliest form of skin cancer
• But relationship between mole pattern, thickness and cancer is complex
• New study found majority of melanoma patients had fewer than 20 moles
• And most had no 'irregular' moles deemed to be dangerous, experts warn
• They say doctors must not rely on mole exams as the only risk factor 

The majority of people diagnosed with the deadliest form of skin cancer have fewer than 20 moles on their body, experts today warned.

The discovery is significant because changing or irregular moles are thought to be a key sign of melanoma. 

Past studies have suggested the number of total moles and atypical moles is associated with a heightened risk of the disease.

But the relationship of those mole patterns with tumor thickness and cancer prognosis is complex.

Now, scientists at Harvard T.H Chan School of Public Health suggest doctors cannot rely on moles as the only warning sign for the disease.

A new study by scientists at Harvard has found the majority of patients diagnosed with melanoma, pictured under the microscope, have fewer than 20 moles on their body and no irregular, or dangerous, moles

Their results showed two in three melanoma patients had fewer than 20 moles on their body.

In addition, very few melanoma patients were found to have 'dangerous' moles.

And almost three-quarters of those analysed had no irregular moles.

Dr Alan Geller, who led the study, said it is still thought the number and type of moles on a person's body is linked to their risk of developing the disease.

But his team's findings show the relationship between those patterns is complex.

Find more: Flibanserin Hydrochloride, CAS 147359-76-0, Testosterone, CAS 58-22-0, Trenbolone acetate, CAS 10161-34-9, Metandienone, CAS 72-63-9, Exemestane, 107868-30-4,